SEC Comment Letter 0000000000-22-012388 to OMEROS CORP (OMER) (CIK 0001285819) (OMER)
OMEROS CORP (OMER) (CIK 0001285819)
Date: Nov. 15, 2022 · CIK: 0001285819 · Accession: 0000000000-22-012388
AI Filing Summary & Sentiment
File numbers found in text: 333-268269
Letter
United States securities and exchange commission logo November 15, 2022 Peter Cancelmo General Counsel and Secretary OMEROS CORP 201 Elliott Avenue West Seattle, WA 98119 Re:OMEROS CORP Registration Statement on Form S-3 Filed November 9, 2022 File No. 333-268269 Dear Peter Cancelmo: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Matthew Franker
Show Raw Text
United States securities and exchange commission logo
November 15, 2022
Peter Cancelmo
General Counsel and Secretary
OMEROS CORP
201 Elliott Avenue West
Seattle, WA 98119
Re:OMEROS CORP
Registration Statement on Form S-3
Filed November 9, 2022
File No. 333-268269
Dear Peter Cancelmo:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Matthew Franker